sub:assertion {
  d:DB00290 dv:ddi-interactor-in dr:DB00290_DB01097 .
  d:DB01097 dv:ddi-interactor-in dr:DB00290_DB01097 .
  dr:DB00290_DB01097 dct:identifier "drugbank_resource:DB00290_DB01097" ;
    dct:title "DDI between Bleomycin and Leflunomide - Immunosuppressants like bleomycin may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity."@en ;
    a dv:Drug-Drug-Interaction ;
    rdfs:label "DDI between Bleomycin and Leflunomide - Immunosuppressants like bleomycin may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased. Consider eliminating the use of a leflunomide loading dose in patients who are receiving other immunosuppressants in order to reduce the risk for serious adverse events such as hematologic toxicity.  [drugbank_resource:DB00290_DB01097]"@en .
}